Flu Drugs May Reduce Cognitive Decline in HIV Patients

Can Flu Drugs Be Repurposed for HIV Treatment?

Researchers at Northwestern University have made a groundbreaking discovery that a class of flu drugs may slow down cognitive decline and premature aging in people living with chronic viral infections, including HIV. The study began with blood samples from HIV patients and progressed to preclinical drug trials. The findings point to a potential new therapy for cognitive impairment.

Health news

Oral GLP‑1 Agent Elecoglipron Triggers Up to 12% Weight Loss in AdultsOceania Genomes Reveal Human Evolution SecretsChemo-Free Treatment Effective in Kids With Aggressive Blood CancerStress and Sleep Deprivation Alter Children's Brains

The study's lead researchers investigated the effects of a class of flu drugs on people with HIV, a condition known to cause cognitive decline and premature aging. By analyzing blood samples, they identified a potential link between the flu drugs and reduced cognitive impairment. Targeting Cognitive Decline in Chronic Viral Infections The researchers found that the flu drugs, known as neuraminidase inhibitors, may help reduce inflammation and oxidative stress, both of which contribute to cognitive decline. The study's results showed that the drugs can improve cognitive function in preclinical models, suggesting a potential therapeutic application.

The discovery has significant implications for the treatment of cognitive

The discovery has significant implications for the treatment of cognitive impairment in people living with HIV. If the findings are confirmed in future studies, the flu drugs could provide a new therapeutic option for patients. The researchers are optimistic about the potential benefits of repurposing existing medications to address cognitive decline in HIV patients.

The study's results offer new hope for people living with HIV and other chronic viral infections, who often experience cognitive decline and premature aging. Frequently Asked Questions What is the class of flu drugs being studied? The class of flu drugs being studied is called neuraminidase inhibitors. How do the flu drugs work to reduce cognitive decline? The flu drugs reduce inflammation and oxidative stress, which contribute to cognitive decline. What are the next steps for the research? The researchers plan to conduct further studies to confirm the findings and explore the potential therapeutic application of the flu drugs.